U.S. market Closed. Opens in 2 days 3 hours 15 minutes

TMCI | Treace Medical Concepts, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue187.12M141.84M94.42M57.37M39.42M
Cost of Revenue35.18M27.52M17.83M12.47M7.63M
Gross Profit151.94M114.31M76.59M44.90M31.79M
Operating Expenses203.37M149.16M93.10M44.04M35.32M
Selling, General & Admin187.93M135.57M82.90M38.19M30.25M
Research & Development15.44M13.58M10.20M5.85M5.07M
Other Operating Expenses342.00K-403.00K1.00KN/AN/A
Operating Income-51.43M-34.84M-16.51M-891.00K-3.54M
Other Expenses / Income1.90M-7.97M-4.04M-2.78M-730.00K
Before Tax Income-49.53M-42.81M-20.55M-3.67M-4.26M
Income Tax Expenses5.18M4.48M4.06M2.78M841.00K
Net Income-49.53M-47.30M-24.61M-6.45M-5.11M
Interest Expenses5.17M4.40M4.06M2.78M841.00K
Basic Shares Outstanding60.85M55.28M54.18M51.17M51.17M
Diluted Shares Outstanding60.85M55.28M54.18M51.17M51.17M
EBITDA-46.08M-31.80M-15.81M319.00K-2.63M
EBITDA Margin-24.62%-22.42%-16.74%0.56%-6.67%
EBIT-39.18M-38.42M-16.49M-891.00K-3.42M
EBIT Margin-20.94%-27.09%-17.47%-1.55%-8.69%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙